Skip to search.
 TSX Up 0.84% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM

7.10 Down 0.14(1.93%) May 17, 4:00PM EDT

Add to Portfolio
Prev Close:7.24
Open:7.13
Bid:5.57 x 200
Ask:7.49 x 500
1y Target Est:10.50
Beta:2.042
Next Earnings Date:N/A
Day's Range:7.03 - 7.25
52wk Range:4.02 - 7.89
Volume:86,450
Avg Vol (3m):54,719
Market Cap:255.65M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
RGLSDown 1.93%255.65M
PFZ.L 0.00%173.71B
GSK.LUp 0.29%82.95B
AZN.LDown 0.45%42.18B
JNJ.MXUp 0.01%3.00T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.59
Quarterly EPS Est (Jun-13) :-0.13
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of microRNA therapeutics to treat a range of diseases primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback